Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
3TR-ICS COPD
NCT06334575Phase 4Recruiting
- Start
- Feb 2025
- Primary completion
- Dec 2027
- Modality
- Orthosteric Ligands
- Countries
- 4
01
Overview
A Phase 4 trial of budesonide in chronic obstructive pulmonary disease (COPD). Started Feb 2025; status: recruiting.
02
Drugs
budesonide
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT06334575.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06334575.